WebLog Journal of Cancer and Clinical Research
WebLog Journal of Cancer and Clinical Research flyer image is not found.
About WebLog Journal of Cancer and Clinical Research

WebLog Journal of Cancer and Clinical Research is an open access publication dedicated to advancing the translational bridge between laboratory discovery and clinical oncology practice. The journal welcomes manuscripts that open new possibilities for cancer understanding, prevention, diagnosis, and therapy, incorporating major discoveries in basic cancer research alongside applied clinical findings. It serves as a resource for oncologists, cancer researchers, and allied health professionals seeking the most recent developments across the cancer research spectrum.

Areas of particular interest include large-scale molecular characterization of human tumors, mechanisms underlying malignant progression and metastatic disease, molecular biomarkers predicting treatment response or resistance, translational research in targeted therapies, personalized medicine, tumor immunotherapy, and novel techniques with potential clinical application. The journal covers the full spectrum of site-specific cancers, including breast, lung, gastrointestinal, genitourinary, gynecologic, head and neck, hematologic, and pediatric malignancies.

Submissions addressing therapeutic modalities such as surgical oncology, radiation oncology, chemotherapy, immunotherapy, hormone therapy, and bone marrow transplantation are equally welcomed, alongside research in cancer epidemiology, genomics, cellular and molecular pathogenesis, and emerging subspecialties such as cardio-oncology and dermatological oncology.

WebLog Journal of Cancer and Clinical Research accepts Research Articles, Review Articles, Systematic Reviews, Short Communications, Case Reports, Clinical Images, Editorials, Perspectives, and Letters to the Editor, allowing authors to report clinical trial results, mechanistic discoveries, or instructive patient case observations.

Every manuscript undergoes a confidential specialist-review pathway conducted by an international editorial board of cancer and clinical research experts, ensuring that published work meets rigorous standards of scientific validity. The journal maintains an efficient publication timeline, with initial decisions typically issued within 21 days of submission and accepted manuscripts published online within 7-10 days thereafter.

All articles are distributed under a Creative Commons license permitting free reuse with attribution, and each receives a permanent DOI for reliable citation. Published content is indexed through OpenAIRE and discoverable via Google Scholar, with long-term preservation ensured through Zenodo archival, and a scannable QR code accompanies every article for instant access to the published version.

Read More